VIH : un vaccin à injection unique pour faire disparaître le virus ?

Researchers at Tel Aviv University have discovered a new technique that could revolutionize the treatment of HIV patients. Current treatments do not completely eliminate the virus.

Could a new treatment make HIV disappear in a sick person ? A team of researchers from Tel Aviv University has developed a unique treatment against AIDS, in the form of a vaccine or a one-time treatment. The results (after tests carried out on mice) were published on June 9, 2022 in the journal Nature biotechnology : “All model animals that received the treatment responded and had large amounts of the desired antibody in their blood.“, indicates the study.

Over the past 20 years, progress in HIV treatment has been considerable and has already improved the daily lives of many patients. Today it is mainly treated by theadministration of antiviral drugs which will block the multiplication of the virus, thus changing the disease from fatal to chronic. This treatment is nevertheless heavy because of its daily intake (risk of forgetting the tablet) and its many side effects: increased cardiovascular risk, impaired renal and hepatic functions or even osteoporosis.

If a first treatment based on an injection of antiretrovirals (rilpivirine and cabotegravir) every two months was authorized – and therefore reimbursed – in 2021, it does not however allow the total elimination of the virus which remains in the body under a diminished form.

This new technique was developed from genetically modified B lymphocytes live, that is to say inside the sick organism itself. B cells are white blood cells that help detect and eliminate pathogens such as viruses, bacteria and parasites. And if studies had already shown that it was possible to transplant B lymphocytes from a donor, either ex-vivothis is the first time that B cells have been genetically modified live as part of this treatment. “We have developed an innovative treatment that can defeat the virus with a single injection, with the potential to bring about a dramatic improvement in the condition of patients.“, welcomes Dr. Adi Barzel, lead author of the study, in a press release.

How does the treatment work?

To modify them, the researchers used a revolutionary genetic tool: the CRISPR-Cas9 system or “genetic scissors”. Cas9 is a bacterial protein that has antiviral properties and has the ability to cut genetic material at a very specific location in the genome. CRISPR-Cas9 technology is used today to turn off unwanted genes or on the contrary, repair or insert genes. “We incorporate the ability of a CRISPR to direct the introduction of genes into desired sites as well as the abilities of viral carriers to deliver desired genes to desired cells. Thus, we are able to engineer the B cells inside the patient’s body.”said doctoral student Alessio Nehmad.

The treatment is also scalable over time. “If the virus changes, the B cells will also change accordingly in order to fight it, so we created the first drug that can evolve in the body“, concludes Dr. Barzel.

In addition to infectious diseases, this revolutionary technology could also be applied to other diseasessuch as cervical cancer, neck and head cancers or autoimmune diseases.


  • In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice, NatureJune 9, 2022
  • A new technology offers treatment for HIV infection through a single injection, EurekAlertJune 13, 2022

Read also:

Subscribe to the Top Santé Newsletter to receive the latest news for free

#HIV #single #injection #vaccine #virus #disappear

Leave a Reply

Your email address will not be published.